Emerging trends in tuberculosis therapy—A review

Abstract

Tuberculosis is one of the most devastating bacterial disease having high rates of morbidity and mortality. Mycobacterium tuberculosis invades the host immune system and persists in pulmonary granulomas. Review presents bacterial cell wall or envelope structure, drug targets against M. tuberculosis and novel therapeutics agents like quinolone, pyrimidine, nitroimidazopyran and oxazolidinone derivatives. This review also focuses on the newer untouched targets like immunomodulators and isocitrate lyase inhibitors, which can be further exploited.